No Evidence That Live Vaccines Are Unsafe for Patients on Dupilumab
There is no evidence to suggest that administration of live vaccines to patients receiving dupilumab is unsafe, and vaccine efficacy is not affected by dupilumab, according to a position paper published online June 5 in theĀ Annals of Allergy, Asthma & Immunology.